Latest Distributions News

SelfWealth Ltd reported a 4% revenue increase and sustained profitability in H1 2025, while advancing a major transformation program and entering a proposed acquisition deal with Bell Financial Group.

FleetPartners Group Limited reported strong FY24 results with record new business writings and assets under management, underpinning a robust growth trajectory and a significant $30 million share buy-back announced for 1H25.

Betashares Mrtn Currie Eqy Inc Fund (EINC) units have been suspended from trading on the ASX as of 22 January 2025, following a prior announcement in December 2024.

Global X Management (AUS) Limited has announced estimated distribution amounts for its Australian-listed ETFs for the period ending January 31, 2025, providing clarity on upcoming income payments.

Australian Foundation Investment Company Limited (AFIC) has announced a fully franked dividend of AUD 0.12 per share for the half-year ending December 2024, accompanied by Dividend Reinvestment and Bonus Security Plans.

Audeara has officially launched its Clinico Sound Earbuds CS1 in Taiwan through a strategic partnership with Clinico Inc., marking a key step in its international expansion and tapping into a growing hearing health market.

Matsa Resources has completed a 767m diamond drill hole at Fortitude North, designed to validate a novel seismic model indicating potential gold mineralisation. Early geological observations support the seismic data, setting the stage for further exploration.

Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.

Amcor plc has entered a definitive agreement to acquire Berry Global Group in a $9.9 billion all-stock transaction, aiming to create a global packaging leader. The merger, pending shareholder and regulatory approvals, is expected to close mid-2025.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.

First Graphene Limited strengthens its financial footing with a UK R&D tax rebate and expands its global footprint through new distribution agreements in India and Brazil.